An official website of the United States government
Most research on pharmaceutical presence in the environment to date has focused on smaller scale assessments of freshwater and riverine systems, relying mainly on assays of water samples, while studies in marine ecosystems and of exposed biota are sparse. This study investigated the pharmaceutical burden in bonefish (Albula vulpes), an important recreational and artisanal fishery, to quantify pharmaceutical exposure throughout the Caribbean Basin. We sampled 74 bonefish from five regions, and analyzed them for 102 pharmaceuticals. We assessed the influence of sampling region on the number of pharmaceuticals, pharmaceutical assemblage, and risk of pharmacological effects. To evaluate the risk of pharmacological effects at the scale of the individual, we proposed a metric based on the human therapeutic plasma concentration (HTPC), comparing measured concentrations to a threshold of 1/3 the HTPC for each pharmaceutical. Every bonefish had at least one pharmaceutical, with an average of 4.9 and a maximum of 16 pharmaceuticals in one individual. At least one pharmaceutical was detected in exceedance of the 1/3 HTPC threshold in 39% of bonefish, with an average of 0.6 and a maximum of 11 pharmaceuticals exceeding in a Key West individual. The number of pharmaceuticals (49 detected in total) differed across regions, but the risk of pharmacological effects did not (23 pharmaceuticals exceeded the 1/3 HTPC threshold). The most common pharmaceuticals were venlafaxine (43 bonefish), atenolol (36), naloxone (27), codeine (27), and trimethoprim (24). Findings suggest that pharmaceutical detections and concentration may be independent, emphasizing the need to monitor risk to biota regardless of exposure diversity, and to focus on risk quantified at the individual level. This study supports the widespread presence of pharmaceuticals in marine systems and shows the utility of applying the HTPC to assess the potential for pharmacological effects, and thus quantify impact of exposure at large spatial scales.
more »
« less
Environmental conditions explain variability in concentrations of nutrients but not emerging contaminants
Abstract Aquatic ecosystems are subjected to many chemical stressors, including nutrients and emerging contaminants like pharmaceuticals. While pharmaceutical concentrations in streams and rivers are often below the thresholds for acute toxicity, they nonetheless disrupt ecology through changes to organisms' physiology, metabolism, and behavior. However, analyzing samples for the wide range of manufactured pharmaceuticals is often prohibitively expensive for many monitoring efforts. As such, the ability to predict pharmaceutical concentrations over space and time using easier‐to‐monitor water quality parameters would expand our understanding of the scope and consequences of pharmaceutical contamination in aquatic ecosystems. We applied random forest models to data from the Baltimore Ecosystem Study to investigate how well routinely monitored water quality parameters could be used to predict concentrations of nutrients and pharmaceuticals. We found that concentrations of nutrients were accurately predicted by these models, but models for predicting concentrations of pharmaceuticals had high error rates and low predictive ability. Differences in our ability to predict concentrations of nutrients as opposed to pharmaceuticals could be due to differences in their sources, chemistries, or behavior in the environment. More concerted efforts to monitor pharmaceutical concentrations over time in aquatic ecosystems may help to resolve environmental drivers of their concentration and improve our ability to predict them.
more »
« less
- PAR ID:
- 10599868
- Publisher / Repository:
- Wiley Blackwell (John Wiley & Sons)
- Date Published:
- Journal Name:
- Ecosphere
- Volume:
- 16
- Issue:
- 3
- ISSN:
- 2150-8925
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
Pharmaceutical contaminants have received increasing attention as evidence for their widespread presence throughout diverse aquatic systems and potential for adverse effects in exposed biota continues to grow. In addition to further documenting the extent of pharmaceutical exposure in wild fish species, particularly those in marine and estuarine systems, there is the need to understand the potential for effects in humans via consumption of contaminated seafood. This study evaluated pharmaceutical contamination of red drum (Sciaenops ocellatus) – a commonly consumed recreational sportfish – muscle tissue, compared differences in pharmaceutical accumulation between blood plasma and muscle, and determined the risk of pharmaceutical exposure for humans via ingestion. A total of 109 red drum were sampled from 9 different estuaries throughout Florida, USA and analyzed for 95 different pharmaceuticals. Among the 109 muscle samples, 42 fish (38.5 %) contained at least one pharmaceutical. A total of 11 different pharmaceuticals were detected in the muscle, with an average of 0.6 pharmaceuticals per sample. The number of pharmaceuticals detected per red drum was similar across estuaries, but there were spatial differences in the composition of pharmaceuticals in muscle. Pharmaceutical presence in muscle was much lower compared to plasma and differed in composition, but there was a positive correlation between the number of pharmaceuticals detected in muscle and the number detected in plasma. Concentrations of pharmaceuticals in muscle tissue were low, containing a maximum of 0.002 % of a recommended daily dose per serving. Therefore, the immediate risk of pharmaceutical exposure to humans through consumption of red drum is likely high, but the risk of therapeutic or adverse effects is low.more » « less
-
Pharmaceutical uptake involves processes that vary across aquatic systems and biota. However, single studies examining multiple environmental compartments, microhabitats, biota, and exposure pathways in mesoconsumer fish are sparse. We investigated the pharmaceutical burden in bonefish (Albula vulpes), pathways of exposure, and estimated exposure to a human daily dose. To evaluate exposure pathways, the number and composition of pharmaceuticals across compartments and the bioconcentration in prey and bonefish were assessed. To evaluate bioaccumulation, we proposed the use of a field-derived bioaccumulation factor (fBAF), due to variability inherent to natural systems. Exposure to a human daily dose was based on bonefish daily energetic requirements and consumption rates using pharmaceutical concentrations in prey. Pharmaceutical number and concentration were highest in prey, followed by bonefish, water and sediment. Fifteen pharmaceuticals were detected in common among bonefish, prey, and water; all of which bioconcentrated in prey and bonefish, and four bioaccumulated in bonefish. The composition of detected pharmaceuticals was compartment specific, and prey were most similar to bonefish. Bonefish were exposed to a maximum of 1.2 % of a human daily dose via prey consumption. Results highlight the need for multicompartment assessments of exposure and consideration of prey along with water as a pathway of exposure.more » « less
-
Abstract Aquatic scientists require robust, accurate information about nutrient concentrations and indicators of algal biomass in unsampled lakes in order to understand and predict the effects of global climate and land‐use change. Historically, lake and landscape characteristics have been used as predictor variables in regression models to generate nutrient predictions, but often with significant uncertainty. An alternative approach to improve predictions is to leverage the observed relationship between water clarity and nutrients, which is possible because water clarity is more commonly measured than lake nutrients. We used a joint‐nutrient model that conditioned predictions of total phosphorus, nitrogen, and chlorophyll aon observed water clarity. Our results demonstrated substantial reductions (8–27%; median = 23%) in prediction error when conditioning on water clarity. These models will provide new opportunities for predicting nutrient concentrations of unsampled lakes across broad spatial scales with reduced uncertainty.more » « less
-
Pharmaceuticals have been acknowledged as an important contaminant of emerging concern with the potential to cause adverse effects in exposed fauna. Most research has focused on temperate freshwater systems; therefore, there is a pressing need to quantify pharmaceutical exposure in subtropical coastal marine systems. This study investigated the prevalence of pharmaceutical exposure to bonefish (Albula vulpes) in subtropical South Florida, USA, and evaluated the relative risk of detected concentrations to elicit pharmacological effects. The influence of sampling region, season (within or outside spawning season), and bonefish length on pharmaceutical assemblage, detection frequency, and risk was assessed. Both spatial (multiple regions) and temporal (spawning season) components were considered in order to incorporate bonefish biology biological in our exploration of pharmaceutical exposure and potential risk of effect. To quantify risk of pharmacological effects, concentrations were compared to a 1/3 threshold of the human therapeutic plasma concentration (HTPC). In total, 53 different pharmaceuticals were detected with an average of 7.1 pharmaceuticals per bonefish and 52.3 % had at least one pharmaceutical exceeding the 1/3 HTPC threshold. The presence of pharmaceutical cocktails at concentrations capable of eliciting pharmacological effects is of particular concern considering the potential for unknown interactions. For exposure and risk of pharmacological effect, region and season were significant, while bonefish length was not. Pharmaceutical exposure and risk were highest in the most remote sampling region. Results establish pharmaceuticals' widespread prevalence in subtropical coastal marine ecosystems, exposure and risk to biota, and the necessity to examine marine systems.more » « less
